Scion Asset Management LLC
The positions Scion Asset Management LLC reported on its Form 13F for Q3 2025, the quarter ending 30 Sept 2025, filed on 3 Nov 2025. Every figure below is the filing’s own: US-listed long equity, valued at the quarter end, with the change measured against the same manager’s previous filing.
Opened this quarter
A new position is the clearest thing a filing says. Somebody argued for it recently, and it is the easiest question to be ready for.
- Palantir Technologies Inc (PLTR)$912m · 66%
- Nvidia Corporation (NVDA)$187m · 14%
- Pfizer Inc (PFE)$153m · 11%
- Halliburton Co (HAL)$62m · 4.5%
- Molina Healthcare Inc (MOH)$24m · 1.7%
- SLM Corp$13m · 1.0%
- Bruker Corp$13m · 1.0%
Sold out of this quarter
Exits are valued at what the position was worth in the previous filing, because by this one it is gone.
- Unitedhealth Group Inc (UNH)$115m held before
- Regeneron Pharmaceuticals (REGN)$113m held before
- Meta Platforms Inc (META)$74m held before
- Lauder Estee Cos Inc$53m held before
- Jd.com Inc$33m held before
- Alibaba Group HLDG LTD$28m held before
- Asml Holding N V$20m held before
- V F Corp (VFC)$18m held before
- Bruker Corp$10m held before
- Mercadolibre Inc (MELI)$7.8m held before
Every reported position, Q3 2025
8 positions, sorted by weight
| Position | Weight ↓ | Value | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
Palantir Technologies Inc (PLTR) CL A PUT · CUSIP 69608A108 | 66% | $912m | 5,000,000 | No earlier filing | New |
Nvidia Corporation (NVDA) COM PUT · CUSIP 67066G104 | 14% | $187m | 1,000,000 | No earlier filing | New |
Pfizer Inc (PFE) COM CALL · CUSIP 717081103 | 11% | $153m | 6,000,000 | No earlier filing | New |
Halliburton Co (HAL) COM CALL · CUSIP 406216101 | 4.5% | $62m | 2,500,000 | No earlier filing | New |
Molina Healthcare Inc (MOH) COM · CUSIP 60855R100 | 1.7% | $24m | 125,000 | No earlier filing | New |
Lululemon Athletica Inc (LULU) COM · CUSIP 550021109 | 1.3% | $18m | 100,000 | +$5.9m +50,000 shares | Added |
SLM Corp COM · CUSIP 78442P106 | 1.0% | $13m | 480,054 | No earlier filing | New |
Bruker Corp 6.375 PREF SER A · CUSIP 116794207 | 1.0% | $13m | 48,334 | No earlier filing | New |
Every filing on file
| Quarter | Period end | Filed | Book | Positions | Top 10 | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | 30 Sept 2025 | 3 Nov 2025 | $1.4bn | 8 | 100% | 13F-HR |
| Q2 2025 | 30 Jun 2025 | 14 Aug 2025 | $578m | 15 | 92% | 13F-HR |
| Q1 2025 | 31 Mar 2025 | 15 May 2025 | $199m | 7 | 100% | 13F-HR |
| Q4 2024 | 31 Dec 2024 | 14 Feb 2025 | $77m | 13 | 94% | 13F-HR |
| Q3 2024 | 30 Sept 2024 | 14 Nov 2024 | $130m | 11 | 99% | 13F-HR |
| Q2 2024 | 30 Jun 2024 | 14 Aug 2024 | $53m | 10 | 100% | 13F-HR |
| Q1 2024 | 31 Mar 2024 | 15 May 2024 | $104m | 16 | 75% | 13F-HR |
| Q4 2023 | 31 Dec 2023 | 16 Feb 2024 | $95m | 25 | 55% | 13F-HR |
Taking this into the room
Pick one name from the top of the book and one from the new positions, and know both properly: what the company earns, what it is priced at, and what has to be true for the position to work. That is a conversation. Reciting the whole table is not, and the interviewer wrote it.
A position sold out of is worth as much preparation as one opened. Ask what changed rather than asserting the fund was wrong, and be ready for the answer that the thesis played out and the money went somewhere better.
What this filing leaves out
A 13F covers US-listed long equity at one moment in time. Shorts, bonds, cash, private positions and non-US listings never appear, and options are reported in a form that will mislead you if you read them as a position. A long/short manager showing $8bn here may run a book several times that size.
The lag matters too. Positions are as at the quarter end and the filing arrives up to forty-five days later, so what you are reading is at least six weeks old and possibly four months. Phrase it as what the filing showed, not what the fund holds today.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More